Oncogenic receptor tyrosine kinases, RAS/MAP kinase, PI3K/AKT/S6K, DYRK1A, PKC and histone deacetylases can enhance the transcriptional activity of GLI in human cancer cells [15-21]. The gene discussed is GLI1; the disease is cancer.